脂质蓄积指数与中国成年人高血压关系的meta分析

doi:10.3969/j.issn.1674-8115.2023.04.009

上海交通大学学报（医学版） ›› 2023, Vol. 43 ›› Issue (4): 466-473.doi: 10.3969/j.issn.1674-8115.2023.04.009

• 论著 · 循证医学 • 上一篇

脂质蓄积指数与中国成年人高血压关系的meta分析

马卓然¹^,²(), 袁安彩², 蒋惠如², 陈潇雨³, 张薇²(), 卜军²()

^1.蚌埠医学院公共卫生学院，蚌埠 233030
^2.上海交通大学医学院附属仁济医院心内科，上海 200127
^3.上海交通大学医学院附属仁济医院临床研究中心，上海 200127

收稿日期:2022-10-25 接受日期:2023-03-14 出版日期:2023-04-28 发布日期:2023-04-28
通讯作者: 张薇,卜军 E-mail:asd3ggb@qq.com;zhangwei050080@renji.com;pujun310@hotmail.com
作者简介:马卓然（1998—），女，硕士生；电子信箱：asd3ggb@qq.com。
基金资助:
上海市专业技术服务平台建设项目(22DZ2292400);上海市卫生健康委员会新兴交叉领域研究专项(2022JC013);上海市卫生健康委员会临床重点专科建设项目(SHSLCZDZK06204)

Meta analysis of correlation between lipid accumulation product and hypertension in Chinese adults

MA Zhuoran¹^,²(), YUAN Ancai², JIANG Huiru², CHEN Xiaoyu³, ZHANG Wei²(), PU Jun²()

^1.School of Public Health, Bengbu Medical College, Bengbu 233030, China
^2.Department of Cardiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
^3.Center for Clinical Investigation, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China

Received:2022-10-25 Accepted:2023-03-14 Online:2023-04-28 Published:2023-04-28
Contact: ZHANG Wei,PU Jun E-mail:asd3ggb@qq.com;zhangwei050080@renji.com;pujun310@hotmail.com
Supported by:
Key Research Center Construction Project of Shanghai(22DZ2292400);Emerging Interdisciplinary Research Project of Shanghai Municipal Health Commission(2022JC013);Key Clinical Specialty of Shanghai Municipal Health Commission(SHSLCZDZK06204)

摘要/Abstract

摘要：

目的·探讨脂质蓄积指数（lipid accumulation product，LAP）与中国成年人高血压的关系。方法·通过检索英文数据库PubMed、Web of Science，中文数据库中国知网、万方数据知识服务平台，搜集从建库到2022年8月中国成年人LAP与高血压相关研究。由2位研究人员根据纳入和排除标准分别独立地对所有检索到的文献进行筛选，并使用JBI（Joanna Briggs Institute）诊断性研究量表对研究人群选择、可比性、暴露评价和结果等方面进行文献质量评估。对纳入的文献提取样本量、性别、灵敏度、特异度等信息，并使用Stata 16.0软件进行meta分析。结果·共纳入6篇文献，其中英文文献5篇，中文文献1篇。纳入文献的JBI偏倚评分为14~17分，均大于总分的70%，认为偏倚较小。纳入样本总数48 329例，其中高血压患者15 746例。Meta分析结果显示，在总人群中，LAP预测高血压的灵敏度为0.50（95%CI 0.35~0.64），特异度为0.78（95%CI 0.66~0.86）；在女性中灵敏度为0.48（95%CI 0.32~0.64），特异度为0.77（95%CI 0.64~0.86）；在男性中灵敏度为0.56（95%CI 0.39~0.72），特异度为0.64（95%CI 0.49~0.77）。纳入的总体人群综合受试者操作特征曲线（summary receiver operator characteristic curve，SROC曲线）下面积为0.70（95%CI 0.66~0.74），表明LAP和高血压存在一定的相关性。结论·在中国成年人群中，LAP与高血压有一定关联性。

关键词: 脂质蓄积指数, 高血压, 成年人, 中国人, meta分析

Abstract:

Objective ·To explore the correlation between lipid accumulation product (LAP) and hypertension in Chinese adults. Methods ·By searching the English literature databases including PubMed and Web of Science, and the Chinese literature databases including CNKI and WanFang Data Knowledge Service Platform database, the earliest literature related to LAP and hypertension in Chinese adults that could be retrieved from databases establishment to August 2022. Two researchers independently screened all the retrieved literature according to the inclusion and exclusion criteria, and used the diagnostic research scale developed by Joanna Briggs Institute (JBI) to evaluate the literature quality of the selection, comparability, exposure evaluation and results of the study population. The sample size, gender, sensitivity, specificity and other information were extracted from the included literature. Stata 16.0 software was used for meta-analysis. Results ·A total of 6 articles were included, including five in English and one in Chinese. The JBI bias scores of the included articles ranged from 14 to 17 points, all of which were greater than 70% of the total score, so the biases could be considered small. The total number of samples included was 48 329, including 15 746 patients with hypertension. The results of meta-analysis showed that in the total population, the sensitivity of LAP in predicting hypertension was 0.50 (95%CI 0.35?0.64), and the specificity was 0.78 (95%CI 0.66?0.86); In women, the sensitivity was 0.48 (95%CI 0.32?0.64), and the specificity was 0.77 (95%CI 0.64?0.86); In males, the sensitivity was 0.56 (95%CI 0.39?0.72), and the specificity was 0.64 (95%CI 0.49?0.77). The area under the summary receiver operator characteristic curve (SROC curve) of the total population included was 0.70 (95%CI 0.66?0.74), indicating that there was a certain correlation between LAP and hypertension. Conclusion ·In Chinese adult population, LAP is associated with hypertension to a certain extent.

Key words: lipid accumulation product (LAP), hypertension, adult, Chinese, meta-analysis

中图分类号:

R181.3⁺7

马卓然, 袁安彩, 蒋惠如, 陈潇雨, 张薇, 卜军. 脂质蓄积指数与中国成年人高血压关系的meta分析[J]. 上海交通大学学报（医学版）, 2023, 43(4): 466-473.

MA Zhuoran, YUAN Ancai, JIANG Huiru, CHEN Xiaoyu, ZHANG Wei, PU Jun. Meta analysis of correlation between lipid accumulation product and hypertension in Chinese adults[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(4): 466-473.

图/表 5

参考文献 43

1	OPARIL S, ACELAJADO M C, BAKRIS G L, et al. Hypertension[J]. Nat Rev Dis Primers, 2018, 4: 18014.
2	徐婷玲, 周脉耕, 刘江美, 等. 1990年与2019年中国居民归因于高血压的死亡负担分析[J]. 中国慢性病预防与控制, 2022, 30(5): 327-331, 335.
	XU T L, ZHOU M G, LIU J M, et al. Death burden attributable to hypertension in 1990 and 2019 in China[J]. Chinese Journal of Prevention and Control of Chronic Diseases, 2022, 30(5): 327-331, 335.
3	MENDOZA M F, KACHUR S M, LAVIE C J. Hypertension in obesity[J]. Curr Opin Cardiol, 2020, 35(4): 389-396.
4	FRAYN K N, KARPE F, FIELDING B A, et al. Integrative physiology of human adipose tissue[J]. Int J Obes, 2003, 27(8): 875-888.
5	HALL J E, DO CARMO J M, DA SILVA A A, et al. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms[J]. Circ Res, 2015, 116(6): 991-1006.
6	SARDINHA L B, TEIXEIRA P J, GUEDES D P, et al. Subcutaneous central fat is associated with cardiovascular risk factors in men independently of total fatness and fitness[J]. Metabolism, 2000, 49(11): 1379-1385.
7	VAN PELT R E, EVANS E M, SCHECHTMAN K B, et al. Contributions of total and regional fat mass to risk for cardiovascular disease in older women[J]. Am J Physiol Endocrinol Metab, 2002, 282(5): E1023-E1028.
8	GÓMEZ-AMBROSI J, SILVA C, GALOFRÉ J C, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity[J]. Int J Obes (Lond), 2012, 36(2): 286-294.
9	KAHN H S. The lipid accumulation product performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison[J]. BMC Cardiovasc Disord, 2005, 5: 26.
10	PICHÉ M E, TCHERNOF A, DESPRÉS J P. Obesity phenotypes, diabetes, and cardiovascular diseases[J]. Circ Res, 2020, 126(11): 1477-1500.
11	CHANG K T, CHEN C H, CHUANG H H, et al. Which obesity index is the best predictor for high cardiovascular disease risk in middle-aged and elderly population?[J]. Arch Gerontol Geriatr, 2018, 78: 165-170.
12	HSU H S, LIU C S, PI-SUNYER F X, et al. The associations of different measurements of obesity with cardiovascular risk factors in Chinese[J]. Eur J Clin Invest, 2011, 41(4): 393-404.
13	KHANMOHAMMADI S, TAVOLINEJAD H, AMINORROAYA A, et al. Association of lipid accumulation product with type 2 diabetes mellitus, hypertension, and mortality: a systematic review and meta-analysis[J]. J Diabetes Metab Disord, 2022, 21(2): 1943-1973.
14	LI Y L, ZHENG R, LI S T, et al. Association between four anthropometric indexes and metabolic syndrome in US adults[J]. Front Endocrinol (Lausanne), 2022, 13: 889785.
15	WAKABAYASHI I. Associations of blood lipid-related indices with blood pressure and pulse pressure in middle-aged men[J]. Metab Syndr Relat Disord, 2015, 13(1): 22-28.
16	GAO X, WANG G Y, WANG A L, et al. Comparison of lipid accumulation product with body mass index as an indicator of hypertension risk among Mongolians in China[J]. Obes Res Clin Pract, 2013, 7(4): e308-e314.
17	秦真真, 李潮, 叶青, 等. 南京市常住居民脂质蓄积指数与高血压和糖尿病患病风险关系的研究[J]. 中国慢性病预防与控制, 2021, 29(7): 505-509.
	QIN Z Z, LI C, YE Q, et al. Relationship between lipid accumulation product and hypertension or diabetes among adults in Nanjing city[J]. Chinese Journal of Prevention and Control of Chronic Diseases, 2021, 29(7): 505-509.
18	WU Z S, YAO C H, ZHAO D, et al. Cardiovascular disease risk factor levels and their relations to CVD rates in China: results of Sino-MONICA project[J]. Eur J Cardiovasc Prev Rehabil, 2004, 11(4): 275-283.
19	ZHAO L C, STAMLER J, YAN L L, et al. Blood pressure differences between northern and southern Chinese: role of dietary factors: the International Study on Macronutrients and Blood Pressure[J]. Hypertension, 2004, 43(6): 1332-1337.
20	NAZARE J A, SMITH J D, BOREL A L, et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity[J]. Am J Clin Nutr, 2012, 96(4): 714-726.
21	顾莺, 张慧文, 周英凤, 等. JBI循证卫生保健中心关于不同类型研究的质量评价工具: 诊断性研究及经济学评价的质量评价[J]. 护士进修杂志, 2018, 33(7): 598-600.
	GU Y, ZHANG H W, ZHOU Y F, et al. JBI evidence-based health center's quality assessment tool for different types of research: the quality evaluation of diagnostic and economic evaluation[J]. Journal of Nurses Training, 2018, 33(7): 598-600.
22	王家鼎, 李爱兰. 中国南北方地理分界线及其差异[J]. 地理教育, 2009(6): 16.
	WANG J D, LI A L. Geographical demarcation line between north and south of China and its differences[J]. Education of Geography, 2009(6): 16.
23	刘云霞, 王洁贞, 庞春坤, 等. 诊断试验评价的meta分析方法[J]. 中华流行病学杂志, 2005, 26(4): 294-296.
	LIU Y X, WANG J Z, PANG C K, et al. The use of meta-analysis in the evaluation on diagnostic tests[J]. Chinese Journal of Epidemiology, 2005, 26(4): 294-296.
24	YAN S, ZHENG Q H, SUN D M, et al. Diagnostic and predictive values of LAP in hypertension: a cross-sectional study in Chinese population older than 65 years[J]. Int J Hypertens, 2021, 2021: 3066007.
25	SONG J, ZHAO Y Y, NIE S M, et al. The effect of lipid accumulation product and its interaction with other factors on hypertension risk in Chinese Han population: a cross-sectional study[J]. PLoS One, 2018, 13(6): e0198105.
26	WANG H Y, CHEN Y T, SUN G Z, et al. Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population[J]. Postgrad Med, 2018, 130(3): 325-333.
27	罗兰, 李欣宇, 高政南. 大连市中老年人脂质蓄积指数与高血压的相关性研究[J]. 实用老年医学, 2019, 33(11): 1064-1068.
	LUO L, LI X Y, GAO Z N. Correlation between lipid accumulation product index and hypertension in middle-aged and elderly people in Dalian area[J]. Practical Geriatrics, 2019, 33(11): 1064-1068.
28	HUANG J X, BAO X Y, XIE Y X, et al. Interaction of lipid accumulation product and family history of hypertension on hypertension risk: a cross-sectional study in the Southern Chinese population[J]. BMJ Open, 2019, 9(11): e029253.
29	LEE W C, WU P Y, HUANG J C, et al. Sex difference in the associations among obesity-related indices with incident hypertension in a large Taiwanese population follow-up study[J]. J Pers Med, 2022, 12(6): 972.
30	SERAVALLE G, GRASSI G. Obesity and hypertension[J]. Pharmacol Res, 2017, 122: 1-7.
31	YATSUYA H, LI Y Y, HILAWE E H, et al. Global trend in overweight and obesity and its association with cardiovascular disease incidence[J]. Circ J, 2014, 78(12): 2807-2818.
32	CANOY D, BOEKHOLDT S M, WAREHAM N, et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study[J]. Circulation, 2007, 116(25): 2933-2943.
33	SEVEN E, THUESEN B H, LINNEBERG A, et al. Abdominal adiposity distribution quantified by ultrasound imaging and incident hypertension in a general population[J]. Hypertension, 2016, 68(5): 1115-1122.
34	SANDEEP S, GOKULAKRISHNAN K, VELMURUGAN K, et al. Visceral & subcutaneous abdominal fat in relation to insulin resistance & metabolic syndrome in non-diabetic south Indians[J]. Indian J Med Res, 2010, 131: 629-635.
35	SCHLECHT I, GRONWALD W, BEHRENS G, et al. Visceral adipose tissue but not subcutaneous adipose tissue is associated with urine and serum metabolites[J]. PLoS One, 2017, 12(4): e0175133.
36	WOLFGRAM P M, CONNOR E L, REHM J L, et al. In nonobese girls, waist circumference as a predictor of insulin resistance is comparable to MRI fat measures and superior to BMI[J]. Horm Res Paediatr, 2015, 84(4): 258-265.
37	NURDIANTAMI Y, WATANABE K, TANAKA E, et al. Association of general and central obesity with hypertension[J]. Clin Nutr, 2018, 37(4): 1259-1263.
38	SUN H, ZHENG M, WU S, et al. Waist circumference and incidence of hypertension in Chinese adults: observations from the Kailuan Study[J]. Herz, 2017, 42(7): 677-683.
39	KIM E H, LEE J B, KIM S H, et al. Serum triglyceride levels and cardiovascular disease events in Koreans[J]. Cardiology, 2015, 131(4): 228-235.
40	YU Z W, LI X, WANG Y, et al. Association between lipid accumulation product and mild cognitive impairment in patients with type 2 diabetes[J]. J Alzheimers Dis, 2020, 77(1): 367-374.
41	邵琦, 吴毅凌, 江峰, 等. 脂质蓄积指数与糖尿病患病风险的关系[J]. 中华疾病控制杂志, 2022, 26(2): 125-130, 243.
	SHAO Q, WU Y L, JIANG F, et al. The relationship between lipid accumulation product and the risk of diabetes[J]. Chinese Journal of Disease Control & Prevention, 2022, 26(2): 125-130, 243.
42	HOSSEINPANAH F, BARZIN M, ERFANI H, et al. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study[J]. Clin Endocrinol (Oxf), 2014, 81(1): 52-57.
43	HIGGINS J P T. Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified[J]. Int J Epidemiol, 2008, 37(5): 1158-1160.

The first author	Research area	Study time	Hypertension definition	Research type	Total sample size	Number of patients with hypertension	Quality score/point
YAN	Pudong New Area, Shanghai	January, 2012‒March, 2013	Systolic blood pressure (SBP) ≥ 140 mmHg, diastolic blood pressure (DBP) ≥ 90 mmHg, or a history of oral antihypertensive medication	Cross-sectional study	2 092	1 066	15
SONG	Bengbu, Anhui Province	2018	SBP≥140 mmHg, DBP≥90 mmHg, or the subject reported with a medical history of antihypertensive medication	Cross-sectional study	1 777	433	14
WANG	Liaoning Province	2012	Blood pressure level of at least 140/90 mmHg, individuals who were on antihypertensive medications or a prior diagnosis of hypertension	Cross-sectional study	11 400	5 684	17
HUANG	Foshan, Fujian Province	2017	Prehypertension was defined as SBP 120‒139 mmHg and/or DBP 80‒89 mmHg, and hypertension was defined as SBP≥140 mmHg, DBP≥90 mmHg and/or a reported medical history of antihypertensive medication	Cross-sectional study	1 681	458	17
LEE	The Taiwan region	2022	Hypertension was defined as a self-reported history, SBP≥140 mmHg, or DBP≥90 mmHg during follow-up	Cohort study	21 466	3 157	16
LUO	Dalian, Liaoning Province	2011	Blood pressure≥140/90 mmHg and/or persons with confirmed hypertension and receiving treatment	Cross-sectional study	9 913	4 948	14

The first author	Research area	Study time	Hypertension definition	Research type	Total sample size	Number of patients with hypertension	Quality score/point
YAN	Pudong New Area, Shanghai	January, 2012‒March, 2013	Systolic blood pressure (SBP) ≥ 140 mmHg, diastolic blood pressure (DBP) ≥ 90 mmHg, or a history of oral antihypertensive medication	Cross-sectional study	2 092	1 066	15
SONG	Bengbu, Anhui Province	2018	SBP≥140 mmHg, DBP≥90 mmHg, or the subject reported with a medical history of antihypertensive medication	Cross-sectional study	1 777	433	14
WANG	Liaoning Province	2012	Blood pressure level of at least 140/90 mmHg, individuals who were on antihypertensive medications or a prior diagnosis of hypertension	Cross-sectional study	11 400	5 684	17
HUANG	Foshan, Fujian Province	2017	Prehypertension was defined as SBP 120‒139 mmHg and/or DBP 80‒89 mmHg, and hypertension was defined as SBP≥140 mmHg, DBP≥90 mmHg and/or a reported medical history of antihypertensive medication	Cross-sectional study	1 681	458	17
LEE	The Taiwan region	2022	Hypertension was defined as a self-reported history, SBP≥140 mmHg, or DBP≥90 mmHg during follow-up	Cohort study	21 466	3 157	16
LUO	Dalian, Liaoning Province	2011	Blood pressure≥140/90 mmHg and/or persons with confirmed hypertension and receiving treatment	Cross-sectional study	9 913	4 948	14

[1]	梁妍景, 黄楚贤, 李红艳, 侯黎莉. 维生素E对放疗或化疗导致的口腔黏膜炎有效性的meta分析[J]. 上海交通大学学报（医学版）, 2023, 43(2): 208-214.
[2]	杨玲, 侯黎莉, 赵燕, 陈卫宏, 张金凤, 毛艳. 口腔癌患者张口受限患病率的meta分析[J]. 上海交通大学学报（医学版）, 2023, 43(1): 61-69.
[3]	方芳, 台瑞, 余倩, 章雅青. 预康复对胃肠道择期手术患者术后恢复效果的系统评价[J]. 上海交通大学学报（医学版）, 2023, 43(1): 70-78.
[4]	陈卫宏, 侯黎莉, 杨玲, 毛艳, 张金凤. 冷冻疗法预防头颈癌患者放射性口腔黏膜炎的meta分析[J]. 上海交通大学学报（医学版）, 2022, 42(5): 635-645.
[5]	谭颖超, 杨珺玥, 王莉娜. 白细胞介素-1B-511C/T基因多态性与冠状动脉粥样硬化性心脏病关联的meta分析[J]. 上海交通大学学报(医学版), 2022, 42(2): 197-204.
[6]	钱德伟, 周任, 关礼春, 张航, 虞敏. 吸入一氧化氮气体对外科手术后肾功能损伤和出血影响的meta分析[J]. 上海交通大学学报(医学版), 2022, 42(1): 95-100.
[7]	王毅, 程诚, 沈红艳, 高红艳, 戴悦宁, 易正辉. 经颅磁刺激对阿尔茨海默病患者认知功能及伴痴呆的行为精神症状疗效的meta分析[J]. 上海交通大学学报(医学版), 2021, 41(7): 931-941.
[8]	姚谦, 田英. 中国人群全氟化合物健康风险评估研究进展[J]. 上海交通大学学报(医学版), 2021, 41(6): 803-808.
[9]	刘洁, 谢新民, 支雪梅, 陆静毅. 睡眠时间与糖尿病性视网膜病变风险关系的meta分析[J]. 上海交通大学学报(医学版), 2021, 41(11): 1502-1508.
[10]	陈智灵, 罗晨, 赵康佳, 沈玲, 胡三莲. 2种镇痛方式在结直肠癌术后应用效果的meta分析[J]. 上海交通大学学报(医学版), 2021, 41(10): 1344-1350.
[11]	刘译升1，詹艳丽2，潘辉1，尹家文1，胡玥1，蔡学礼2#，刘建仁1#. 不明原因脑栓塞与心源性脑卒中机械取栓预后的比较[J]. 上海交通大学学报(医学版), 2020, 40(9): 1270-1276.
[12]	胡绪林，陈妍，夏红萍，张拥军. 不同程度小于胎龄儿的母体临床危险因素分析[J]. 上海交通大学学报（医学版）, 2020, 40(4): 489-.
[13]	潘胜珂，李惠，魏燕燕，姚培芬，李华芳. 安慰剂治疗原发性失眠症患者的meta分析[J]. 上海交通大学学报（医学版）, 2020, 40(4): 505-.
[14]	胡哲1，丰青1，邓雪芹1，何嫣1，李明春1，董晨杰2，胡静芬3，张楠3，高妍4，初少莉1，杨晖1#，陈歆1#. 上海嘉定区高血压控制情况及其影响因素[J]. 上海交通大学学报(医学版), 2020, 40(12): 1652-1655.
[15]	林昊，潘建安，张俊峰，顾俊，王长谦. 糖尿病、高血压和心房颤动不同治疗方案对射血分数保留心力衰竭发生的影响[J]. 上海交通大学学报(医学版), 2020, 40(10): 1402-1407.

脂质蓄积指数与中国成年人高血压关系的meta分析

Meta analysis of correlation between lipid accumulation product and hypertension in Chinese adults

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 5

参考文献 43

相关文章 15

编辑推荐

Metrics